東京大学医学系研究科 国際保健政策学 東京大学 The University of Tokyo

Department of Global Health Policy

Graduate School of Medicine, The University of Tokyo

Domestic Health Policy Reform

国内医療政策改革

急速な高齢化、慢性・非感染疾患の増加により、日本の医療システムは新しい複雑化した課題に
適応していく必要があり、それは、医療効果、ヘルスケアにおける不平等、
皆保険制度の継続性などに影響を与える。当研究室ではデータ分析、政府やヘルスケア産業の
ステークホルダーとの政策議論・立案を通じて、日本の医療システムの未来についての考察に貢献している。

Faced with a rapidly ageing population and growth in chronic, non-communicable diseases,
Japan’s health system needs to adapt to a new generation of complex challenges.
These will affect health outcomes, health inequality and the sustainability of Japan’s universal healthcare system.
The Department of Global Health Policy contributes to the debate
about the future of Japan’s health system through data analysis and policy discussion and
formulation with government and health industry stakeholders.

研究員 Researchers: Kenji Shibuya, Erika Ota, Nayu Ikeda 渋谷健司大田えりか池田奈由
研究トピック Research Topics: Health system performance assessment

Recent Publications

Ezoe S, Noda H, Akahane N, Sato O, Hama T, Miyata T, Terahara T, Fujishita M, Sakamoto H, Abe SK, Gilmour S, Shobayashi T. Trends in policy on the prevention and control of non-communicable diseases in Japan. Health Systems & Reform. 2017; Online first.

Read the Article →

Japan Global Health Working Group. Protecting human security: proposals for the G7 Ise-Shima Summit in Japan. The Lancet. 2016; 387 (10033): 2155-2162.

Read the Article →

Reich M, Shibuya K. The Future of Japan's Health System — Sustaining Good Health with Equity at Low Cost. The New England Journal of Medicine. 2015; 373:1793-1797. DOI: 10.1056/NEJMp1410676

Read the Article →

Kanda M, Ota E, Fukuda H, Miyauchi S, Gilmour S, Kono Y, et al. Effectiveness of community-based health services by nurse practitioners: protocol for a systematic review and meta-analysis. BMJ Open. 2015;5:e006670. doi:10.1136/bmjopen-2014-006670

Read the Article →

Miyata H, Ezoe S, Hori M, Inoue M, Oguro K, Okamoto T, Onishi K, Onozaki K, Sakakibara T, Takeuchi K, Tokuda Y, Yamamoto Y, Yamazaki M, Shibuya K, for the Health Care 2035 Advisory Panel. Japan's vision for health care in 2035. The Lancet. 2015; 385 (9987):2549-2550. doi: http://dx.doi.org/10.1016/S0140-6736(15)61135-7

Read the Article →

Gilmour S. Forecasting HIV in Japan. 2015. PhD Thesis. University of Tokyo.

Hanibuchi T, Nakaya T, Honjo K, Ikeda A, Iso H, Inoue M, Sawada N, Tsugane S; Japan Public Health Center-based Prospective Study Group.Neighborhood contextual factors for smoking among middle-aged Japanese: a multilevel analysis. Health & Place. 2015 Jan;31:17-23. doi: 10.1016/j.healthplace.2014.10.010.

Read the Article →

Tanimoto T, Kami M, Shibuya K. Misconduct: Japan to learn from biomedical cases. Nature. 2014; 512: 371. doi:10.1038/512371d [correspondence]

Read the Article →

Shibuya K. Cross-boundary Cancer Studies at the University of Tokyo: The Globalization of Healthcare. Japanese Journal of Clinical Oncology. 2014;44(S1): i69-i73. doi: 10.1093/jjco/hyt219

Read the Article →

Tanimoto T, Kami M, Shibuya K. Research misconduct and scientific integrity: a call for a global forum. The Lancet. 2013; 382(9896):940. doi: 10.1016/S0140-6736(13)61933-9. [correspondence]

Read the Article →

Gilmour S, Kanda M, Kusumi E, Tanimoto T, Kami M, Shibuya K. HPV vaccination programme in Japan. The Lancet. 2013; 382(9894):768. doi: 10.1016/S0140-6736(13)61831-0. [correspondence]

Read the Article →

Miyamoto K. Population based reference birth weights and risk factors for early neonatal death in Japanese twins from 2008 - 2010. 2013. Master's thesis. University of Tokyo.

Kanda M. The introduction of combined haemophilus influenza type b and Pneumococcal conjugate vaccination in infants in Japan: A cost-effectiveness analysis. 2013. Master's Thesis. University of Tokyo.

Hosoda M, Inoue H, Miyazawa Y, Kusumi E, Shibuya K. Vaccine-associated paralytic poliomyelitis in Japan.Lancet. 2012; 379(9815): 520. (correspondence)

Read the Article →

Yamamoto N, Mori R, Jacklin P, Osuga Y, Kawana K, Shibuya K, Taketani Y. Introducing HPV vaccine and scaling up screening procedures to prevent deaths from cervical cancer in Japan: A cost-effectiveness analysis. BJOG. 2012; 119(2): 177-186.

Read the Article →